Liquid Biopsy Market is expected to reach USD 7.1 Bn by 2027

Liquid biopsy market is forecasted to grow at high rate due to an increasesing number of detection technologies, clinical studies, and high prevalence of numerous cancers.The Global Liquid Biopsy Market size was valued at USD 2.4 Bn in 2020 expected to reach USD 7.1 Bn by 2027, with a growing CAGR of 19.9 % during the forecast period

Request a Sample Report- https://www.alltheresearch.com/sample-request/210

Global Liquid Biopsy Market by Region Outlook (Revenue, USD Million, 2021-2027)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Based on region, North America dominated the liquid biopsy market in 2020 and is expected to maintain the same dominance throughout the forecast period. The rising prevalence of numerous cancers, advanced healthcare infrastructure, increase in rapid detection and screening technologies, increasing incidence of various tumor conditions in the population drives the growth of the market in this region.

The Global Liquid Biopsy Market Segmentation:
Global Liquid Biopsy Market by Sample Type Outlook (Revenue, USD Million, 2021-2027)
• Blood Sample
• Urine Sample
• Other Bio Fluids (Tissue fluids and Saliva)

Global Liquid Biopsy Market by Application Outlook (Revenue, USD Million, 2021-2027)
• Therapy Selection for Metastatic Breast Cancer (MBS)
• Therapy Selection for Other Metastatic Cancer
• Molecular Health Monitoring Services
Global Liquid Biopsy Market by Biomarker Outlook (Revenue, USD Million, 2021-2027)
• Circulating Tumour Cells (CTC)
• Circulating Tumour DNA (ctDNA)
• Exosomes

Global Liquid Biopsy Market by Technology Outlook (Revenue, USD Million, 2021-2027)
• Multi-gene-parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

Global Liquid Biopsy Market by End-user Outlook (Revenue, USD Million, 2021-2027)
• Hospitals
• Diagnostic Laboratories
• Others (Research Institutes)

Company Profiles and Competitive Intelligence

The key players operating in the market are:
• Biocept, Inc.
• MDxHealth
• Myriad Genetics, Inc.
• Bio-Rad Laboratories
• QIAGEN
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Genomic Health, Inc.
• Illumina, Inc.
• Vermillion, Inc.
• Foundation Medicine, Inc.
• OncoCyte Corporation
• Veracyte, Inc, Inc.
• Guardant Health, Inc.
• NeoGenomics Laboratories, Inc.
• Personal Genome Diagnostics, Inc.
• RainDance Technologies, Inc.
• Trovagene Inc.
• Adaptive Biotechnologies.
• Cynvenio Biosystems, Inc.

Liquid Biopsy Market

Read More- https://www.alltheresearch.com/report/210/liquid-biopsy